Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

112
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
112

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PET Imaging Characterization of Sphingosine-1-Phosphate Receptor 2 in a Mouse Model of Esophageal Adenocarcinoma and Metastatic Lymph Node.

Molecular pharmaceutics·2026
Same author

Imaging Sphingosine-1-Phosphate Receptor: A Promising Strategy to Neuroinflammation of Epilepsy.

Molecular imaging·2026
Same author

Kinetic Modeling of a Novel Putative Sphingosine-1-Phosphate Receptor 1 (S1PR1) Radiotracer [<sup>18</sup>F]TZ82112 in Nonhuman Primates.

Journal of neurochemistry·2026
Same author

Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.

Cancer discovery·2026
Same author

SLC33A1 exports oxidized glutathione to maintain endoplasmic reticulum redox homeostasis.

Nature cell biology·2026
Same author

Metabolites from plasma-like medium fuel nitrogen metabolism and influence proliferation in <i>Leptospira interrogans</i>.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jun 28, 2025

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

3.4K

Metabolite Study and Structural Authentication for the First-in-Human Use Sphingosine-1-phosphate Receptor 1

Lin Qiu1, Hao Jiang1, Kevin Cho2

  • 1Department of Radiology, Washington University School of Medicine, Saint Louis, Missouri 63110, United States.

ACS Chemical Neuroscience
|April 18, 2024
PubMed
Summary
This summary is machine-generated.

The sphingosine-1-phosphate receptor 1 (S1PR1) radiotracer [11C]CS1P1 is promising for neuroinflammation PET imaging. Its major metabolite, N-oxide [11C]TZ82121, does not cross the blood-brain barrier, ensuring accurate quantitative PET data analysis.

Keywords:
N-oxideS1PR1[11C]CS1P1[18F]FS1P1[18F]TZ82121human clinical studyradiometaboliteradiosynthesis

More Related Videos

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941
09:50

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941

Published on: April 28, 2019

7.5K
Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
09:25

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

6.6K

Related Experiment Videos

Last Updated: Jun 28, 2025

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
12:27

A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors

Published on: June 8, 2022

3.4K
Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941
09:50

Technical Aspect of the Automated Synthesis and Real-Time Kinetic Evaluation of [11C]SNAP-7941

Published on: April 28, 2019

7.5K
Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers
09:25

Solid Phase 11C-Methylation, Purification and Formulation for the Production of PET Tracers

Published on: October 24, 2019

6.6K

Area of Science:

  • Neuroimaging
  • Radiochemistry
  • Pharmacology

Background:

  • Sphingosine-1-phosphate receptor 1 (S1PR1) PET imaging shows promise for neuroinflammation in multiple sclerosis (MS).
  • The radiotracer [11C]CS1P1 has demonstrated potential in proof-of-concept studies.
  • Characterizing radiometabolites that cross the blood-brain barrier is crucial for accurate quantitative modeling of neuroimaging tracers.

Purpose of the Study:

  • To investigate the metabolite profile of [11C]CS1P1 in rats, nonhuman primates, and humans.
  • To identify and characterize the major lipophilic radiometabolite of [11C]CS1P1.
  • To determine if the identified radiometabolite enters the brain and affects PET imaging accuracy.

Main Methods:

  • HPLC radiometabolite analysis of human plasma.
  • Metabolite characterization in rats using nonradioactive CS1P1, followed by LC/MS analysis.
  • Synthesis of mono-oxidized CS1P1 derivatives for comparison.
  • Radiosynthesis of [18F]TZ82121 for brain penetration studies.
  • Biodistribution studies in rats and PET imaging in nonhuman primates.

Main Results:

  • A lipophilic radiometabolite, more lipophilic than [11C]CS1P1, was consistently detected in human, rat, and nonhuman primate plasma.
  • LC/MS analysis identified the metabolite as N-oxide 1 (TZ82121), resulting from in vivo mono-oxidation of CS1P1.
  • Synthesized [18F]TZ82121 did not enter the brain in rats or nonhuman primates, as confirmed by biodistribution and PET imaging.
  • The N-oxide metabolite [11C]TZ82121 does not confound quantitative PET data analysis.

Conclusions:

  • The major lipophilic radiometabolite of [11C]CS1P1, N-oxide [11C]TZ82121, does not enter the brain.
  • [11C]CS1P1 remains a promising S1PR1 radiotracer for CNS imaging.
  • The characterization of this metabolite validates the quantitative analysis of [11C]CS1P1 PET imaging data.